ALGIPHARMA AS

1337 SANDVIKA

Finances

Share Ownership

Return on Equity

−25,36 %

Current Ratio

0,28

Debt-to-Equity Ratio

4,58

Key figures (NOK)	2022	2021	2020	2019
Revenue	40 000	65 000	0	2 488 000
Net Income	−7 073 000	−10 658 000	−12 306 000	−16 082 000
Total Assets	173 351 000	155 526 000	144 458 000	144 606 000
Total Equity	27 888 000	34 962 000	45 619 000	57 925 000

Income (NOK)	2022	2021	2020	2019
Revenue	40 000	65 000	0	2 488 000
Expenditure	7 985 000	6 702 000	8 901 000	16 295 000
Operating Profit	−7 945 000	−6 637 000	−8 902 000	−13 807 000
Financial Income	2 223 000	79 000	519 000	260 000
Financial Costs	1 352 000	4 099 000	3 923 000	2 535 000
Financial Balance	871 000	−4 020 000	−3 404 000	−2 275 000
Earnings Before Tax	−7 073 000	−10 658 000	−12 306 000	−16 082 000
Tax	0	0	0	0
Net Income	−7 073 000	−10 658 000	−12 306 000	−16 082 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	168 449 000	149 488 000	136 144 000	124 753 000
Total Current Assets	4 902 000	6 038 000	8 314 000	19 854 000
Total Assets	173 351 000	155 526 000	144 458 000	144 606 000
Total Retained Equity	0	0	0	0
Total Equity	27 888 000	34 962 000	45 619 000	57 925 000
Total Long-Term Debt	127 767 000	112 260 000	89 336 000	69 089 000
Total Current Debt	17 695 000	8 305 000	9 503 000	17 592 000
Total Equity and Debt	173 351 000	155 526 000	144 458 000	144 606 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	40 000	65 000	0	2 488 000
Other Income	0	0	0	0
Revenue	40 000	65 000	0	2 488 000
Cost of Goods Sold	0	0	4 000	998 000
Salary Costs	2 237 000	2 561 000	2 705 000	2 200 000
Depreciation	0	128 000	143 000	150 000
Impairment	0	0	0	0
Expenditure	7 985 000	6 702 000	8 901 000	16 295 000
Operating Profit	−7 945 000	−6 637 000	−8 902 000	−13 807 000
Financial Income	2 223 000	79 000	519 000	260 000
Financial Costs	1 352 000	4 099 000	3 923 000	2 535 000
Financial Balance	871 000	−4 020 000	−3 404 000	−2 275 000
Dividends	0	0	0	0
Net Income	−7 073 000	−10 658 000	−12 306 000	−16 082 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	167 977 000	149 015 000	135 675 000	123 657 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	5 000	16 000
Total Tangible Assets	0	0	5 000	16 000
Total Fiancial Fixed Assets	473 000	473 000	464 000	1 080 000
Total Fixed Assets	168 449 000	149 488 000	136 144 000	124 753 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	865 000	965 000	1 082 000	10 259 000
Total Current Assets	4 902 000	6 038 000	8 314 000	19 854 000
Total Assets	173 351 000	155 526 000	144 458 000	144 606 000
Total Equity	27 888 000	34 962 000	45 619 000	57 925 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	127 767 000	112 260 000	89 336 000	69 089 000
Creditors	16 096 000	6 891 000	7 843 000	5 153 000
Unpaid Taxes	495 000	545 000	658 000	560 000
Dividends	0	0	0	0
Other Current Debt	1 104 000	868 000	1 001 000	11 880 000
Total Current Debt	17 695 000	8 305 000	9 503 000	17 592 000
Total Equity and Debt	173 351 000	155 526 000	144 458 000	144 606 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−25,36 %	−30,48 %	−26,98 %	−27,76 %
Debt-to-Equity Ratio	4,58	3,21	1,96	1,19
Operating Profit Margin	−19 862,5 %	−10 210,77 %	-	−554,94 %
Current Ratio	0,28	0,73	0,87	1,13
Quick Ratio	0,28	0,73	0,87	1,13
Equity Ratio	0,16	0,22	0,32	0,4
Gross Profit Margin	100 %	100 %	-	59,89 %